Volume 2, Issue 4 (2016)                   Pharm Biomed Res 2016, 2(4): 38-43 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahmadi M, Mahdavi H, Madani M, Hadadi Z. In-vitro inhibitory effect of ethanolic and methanolic extract of Scrophulari astriata on Candida spp.. Pharm Biomed Res. 2016; 2 (4) :38-43
URL: http://pbr.mazums.ac.ir/article-1-144-en.html
1- Research and Development Department, Sinafaravar pharmaceutical Company, Najaf abad, Isfahan, Iran
2- Department of Microbiology, Falavarjan Branch,Islamic Azad University, Isfahan, Iran
Abstract:   (3509 Views)

Candida species are the most common cause of opportunistic fungal infection worldwide. Due to increasing resistance of fungi against conventional drugs, as well as their side effects, alternative natural products have become a renewed interest. In the current study, the anti-Candida activities of Scrophularia striata extract were examined. In this experimental study, microdilution assay and well diffusion test  were used to determine invitro anti-fungal effects of ethanolic and methanolic extract of Scrophulari astriata on four species of Candida including Candida albicans ATCC 1167, ATCC 1677, tropicalis, and glabrata. The results showed that 100 mg/ml methanolic extract has more anticandida activity than ethanolic extract. Diameter of inhibiting growth environment for ethanol extract was 37 mm, and MIC and MFC were 2.1 and 41.5 mm/ml. Results show that ethanolic and methanolic extract of Scrophularia striata have anti-fungal activities. Therefore results of this study suggest this extract is a promising anti-fungal agent, and future experiments will interest for performing in vivo study.

Full-Text [PDF 248 kb]   (1855 Downloads)    

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb